Article
High frequency of HIV-1 drug resistance among individuals with persistent low-level viremia during first-line antiretroviral therapy in Uganda.
BMC infectious diseases - 16 Jun 2026
Sanyu Grace, Mayanja Yunia, Omooja Jonah, Asio Juliet Nkugwa, Nannyonjo Maria, Ssemanda Patrick, Hellen Nansumba, Ssewanyana Isaac, Drago Kato Charles, Kaleebu Pontiano, Ssemwanga Deogratius
Abstract excerpt
BACKGROUND: Although persistent low-level viremia (PLLV) has been associated with treatment failure, there is limited data about HIV drug resistance (HIVDR) during PLLV among Ugandans living with HIV. This study assessed HIVDR prevalence, patterns and associated factors among individuals on HIV-1 first-line antiretroviral therapy (ART) who were experiencing PLLV. METHODS: A cross-sectional study among individuals...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
